Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPO - Novel Approach for Oligospermia
2023-508325-27-00Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Dec 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in male infertility and oligospermia comparing Prolia (denosumab) with Placebo (saline) (2 arms). Primary endpoint: Sperm concentration at day 80. Started Dec 2023; status: completed.
02
Drugs
denosumab
03
Conditions
male infertilityoligospermia
Beyond the preview
Go deeper on 2023-508325-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508325-27-00.